Arcus Biosciences (NYSE:RCUS) reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Arcus Biosciences beat estimated earnings by 17.54%, reporting an EPS of $-0.94 versus an estimate of $-1.14.
Revenue was down $1.58 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 1.26% increase in the share price the next day.
Here’s a look at Arcus Biosciences’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -1 | -1.16 | -1.07 | -1.04 |
| EPS Actual | -1.04 | -1.09 | -0.93 | -0.90 |
| Revenue Estimate | 35.86M | 24.97M | 23.31M | 21.89M |
| Revenue Actual | 29.00M | 25.00M | 34.00M | 33.58M |
To track all earnings releases for Arcus Biosciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
